Posted on July 9th, 2010
Another lawsuit against the maker of the drug Reglan was filed in June, according to court documents.
The newest lawsuit was filed by Israel Bennet, who claims he was prescribed the drug reglan to treat Gastroesophageal Reflux Disease. Bennett says he took the drug regularly for almost five months until he was diagnosed with Tardive Dyskensia. The lawsuit contends that the drug’s manufacturer did not provide him with the right details of the Reglan drug on a long-term basis, and actually provided incorrect and disingenuous information.
Tardive Dyskinesia is a movement disorder characterized by painful and uncontrolled movement of the facial muscles and extremities. Symptoms often include unintentional lip smacking, grimacing, and lip puckering.
If you or a loved one has become ill after use Reglan, contact the Reglan Tardive Dyskinesia attorney of Williams Kherkher by calling 800-761-3187.
Posted on July 8th, 2010
The United States Food and Drug Administration recently required the makers of the drug Reglan to include a black box warning about Tardive Dyskinesia.
A black box warning, also known as a black label warning or a boxed warning, is a type of warning that appears on the package insert for prescription drugs that can cause serious adverse effects. The name comes from the black border that usually surrounds the text of the warning.
A black box warning means that medical studies indicate that the drug carries a significant and substantial risk of serious or life-threatening adverse effects. The U.S. Food and Drug Administration can require a pharmaceutical company to place a boxed warning on the labeling of a prescription drug or any literature detailing it. It is the strongest warning the FDA requires.
The FDA has linked use of the drug Reglan to the debilitating and incurable movement disorder Tardive Dyskensia. For sound legal advice and assistance regarding Reglan side-effects and injury liability, please contact the Reglan Tardive Dyskinesia lawyers of Williams Kherkher today at 800-781-3955.
Posted on July 2nd, 2010
The ever-growing number of lawsuits filed against the manufacturer of the drug Reglan is at the center of debate over whether drug companies are immune from court action at the state level if their products are federally regulated.
There has been ongoing debate about whether generic drug makers are liable for side effects caused by their medications. The drug companies argue that the United States Food and Drug Administration’s mandate that generic drugs carry the same warning labels as their name brand counterparts relieves them of responsibility. This question is the focus of a lawsuit in Cincinnati, Ohio.
A court in Ohio ruled that generic drug maker was not responsible for the Tardive Dyskinesia a man developed after taking a generic form of Reglan. An appeals court is reconsidering the lawsuit and has requested the FDA provide its stance on this label issue, asking that an answer be delivered by July 29.
If you or someone you love has suffered from averse side-effects due to the prescription drug Reglan, call the Reglan tardive dyskinesia attorneys of Williams Kherkher at 800-781-3955 today.
Posted on July 2nd, 2010
It has been more than twenty years since the first Reglan tardive dyskinesia lawsuit was filed, and new lawsuits continue to be brought against the drugs manufacturers.
Reglan, which is also known as generic metrocrlopramide, is a drug approved for the short-term treatment of gastrointestinal disorders. Designed for temporary treatment of diabetic gastroparesis, gastroesophageal reflux (GERD) and delayed gastric emptying, but the dug is often prescribed for longer periods of time. Long-term use of the drug has been shown to greatly increase the risk of tardive dyskinesia in patients.
Tardive dyskinesia is a neurological movement disorder. The disorder causes repetitive and involuntary movement of the face and extremities. Involuntary grimacing, chewing, smacking or pursing of the lips, rapid eye movements and impaired finger movements are common manifestations of the disorder.
If you or a loved one has become ill after use Reglan, contact the Reglan lawsuit attorney of Williams Kherkher by calling 800-761-3187.
Posted on June 18th, 2010
Neurocrine Biosciences, a California-based pharmaceutical firm, has announced an intention to press their tardive dyskinesia treatment into US trials under the federal Food & Drug Administration’s Investigational New Drug program.
A previous trial taken up in Canada among healthy male volunteer candidates offered positive feedback, showing no major negative reactions to the drug treatment, including no substantially abnormal ECG findings. The company characterized the drug’s performance in these first phase tests as well-tolerated and working toward its primary function.
The treatment process inhibits brain chemicals that off-set the levels of dopamine that the brain receives in communications between nerves. Neurocrine notes that this drug also marginalizes any change to other monoamines in the brain, which otherwise could have increased side-effects.
This drug has been offered to the public as a possible treatment for not only tardive dyskinesia, but similar disorders like Tourette’s syndrome and even some forms of schizophrenia.
If you have developed tardive dyskinesia after using the drug Reglan, you may be eligible for compensation from pharmaceutical companies. Contact the Reglan lawsuit attorneys of Williams Kherkher at 800-761-3187 today to discuss your rights and options.
Posted on June 16th, 2010
Since the past year, a black box warning label has marked Reglan as one of the most dangerous prescription drugs on the market. However, the label does not address studies that prove that Reglan does not even live up to its expectations as an effective drug.
The Food & Drug Administration originally approved Reglan in 1979 to combat gastrointestinal problems, especially gastroparesis and gastroesophageal reflex disease. While it took 30 years to issue the black box label to warn patients about possible complications, it did not take 30 years to publish a study to prove that the drug had minimal effectiveness to match its dangerousness.
Studies published in 1975, 1983, and 2006 all pointed to weak or non-existent responses to the drug treatment. In comparison, 1983, 1984, and 1992 saw studies pointing out the risks of Reglan.
Reglan is only supposed to be taken for short-term treatment of gastrointestinal ailments, but has been proven to be ineffective for many of the most needy patients suffering from these disorders.
If you or someone you love has been diagnosed with tardive dyskinesia due to Reglan use, you may be entitled to compensation for your medical bills and suffering. Contact the Reglan tardive dyskenesia lawsuit attorneys of Williams Kherkher today by calling 800-761-3187.
Posted on June 11th, 2010
According to a Louisiana mother, the drug Reglan was responsible for birth defects in her child.
The mother has filed a suit against the manufacturer of the drug, Pliva, Inc. She complained of nausea and vomiting to her doctor, who prescribed Reglan during her seventh week of pregnancy. She took the medicine for roughly four weeks. Around week 32, she complained to her doctor, which was followed by the birth of her son in week 36. The premature birth led to numerous complications that baffled medical staff.
The suit complaint includes charges of multiple emotional complications, permanent disabilities, medical expenses, lost wages, and other financial deficiencies.
The woman claimed that she was unaware of problems with the medication until she saw an advertisement including the side-effects on the television. The medication is not supposed to be prescribed for pregnant mothers, and has been given the Food & Drug Administration’s strongest warning label due to multiple reports of adverse effects.
If you too have been affected by Reglan, you may be entitled to compensation for your suffering. Contact the Reglan side effect attorneys of Williams Kherkher by calling 800-761-3187 today to discuss your claim and possible options.
Posted on June 4th, 2010
With reports of Reglan-related tardive dyskinesia coming to the forefront of numerous lawsuits, it appears that the disorder can affect any number of users along possible demographic lines.
The medication was used beyond its guidelines, originally establishing a three-month period in which the drug could be used before complications could set in. As a result, Reglan accounts for the primary cause of tardive dyskinesia in the United States of America today. Following studies and lawsuits, the Food & Drug Administration put a warning on the drug, noting its connection to tardive dyskinesia.
Although studies have proven that elderly and female patients are more likely to develop the disorder after using the drug, new concerns have brought to light the presence of the drug-related disorder in infants, as well as less talked about cases in otherwise healthy adults. When an adult in their prime develops tardive dyskinesia, the disorder can move from small uncontrollable movements to worsened jerks and spasms. In some industries, the problems associated with this disorder can cause employees to lose their jobs, compromising their livelihoods.
If you or someone you love has been diagnosed with tardive dyskinesia after a treatment that included Reglan, you may be eligible for compensation. Contact the Reglan lawsuit attorneys of Williams Kherkher by calling 800-761-3187 today.
Posted on May 13th, 2010
Following an April case, fears are amounting over use of generic forms of Reglan. Although Federal law requires generic brands to follow a similar warning label and to report cases of negative reactions, many are concerned that these standards are less enforceable in a wider market.
These fears compound with new healthcare reforms, which will make prescription pharmaceuticals more affordable, and therefore available, for patients. In the April case, the plaintiff’s suit against Wyeth and Schwartz, the corporations responsible for Reglan’s production, failed to provide prior authority that could hold a original manufacturer responsible for similar generic drugs.
With less enforcement from the FDA over generic brands, and a possible explosion in the market, some fear that Reglan poses to endanger a new, greater population in the near future.
If you or someone you love has suffered from averse side-effects due to the prescription drug Reglan, call the Reglan tardive dyskinesia attorneys of Williams Kherkher at 800-781-3955 today.
Posted on May 7th, 2010
Researchers are growing concerned about the rise of Reglan side effects in newborns due to the increased prescription of the drug to premature infants.
Reglan, a drug that treats acid reflux, was never approved for infants and was only recommended for short term use by the United States Food and Drug Administration. Last year, the FDA issued a black-box warning to inform physicians and the public of the link between Reglan and serious movement disorders like tardive diskinesia.
The rising use of the drug among newborns has many researchers worried that new side effects and previously unknown health concerns will appear. “Because Reglan has been on the market for over thirty years, many physicians assume the drug is safe and prescribe it for various off-label uses,” said Scott Nabers, a health advocate.
If you or someone you love has suffered serious side effects due to the prescription drug Reglan, contact the Reglan lawsuit attorneys of Williams Kherkher at 800-761-3187 today.
